Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer.
Walker LG, Eremin JM, Aloysius MM, Vassanasiri W, Walker MB, El-Sheemy M, Cowley G, Beer J, Samphao S, Wiseman J, Jibril JA, Valerio D, Clarke DJ, Kamal M, Thorpe GW, Baria K, Eremin O. Walker LG, et al. Among authors: eremin jm, eremin o. BMC Cancer. 2011 May 18;11:179. doi: 10.1186/1471-2407-11-179. BMC Cancer. 2011. PMID: 21592370 Free PMC article. Clinical Trial.
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.
Eremin J, Cowley G, Walker LG, Murray E, Stovickova M, Eremin O. Eremin J, et al. Among authors: eremin o. Springerplus. 2015 Jan 13;4(1):9. doi: 10.1186/2193-1801-4-9. eCollection 2015. Springerplus. 2015. PMID: 25995984 Free PMC article.
Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC.
Kaewkangsadan V, Verma C, Eremin JM, Cowley G, Ilyas M, Eremin O. Kaewkangsadan V, et al. Among authors: eremin o. BMC Cancer. 2018 Feb 2;18(1):123. doi: 10.1186/s12885-018-4044-z. BMC Cancer. 2018. PMID: 29390966 Free PMC article.
223 results